St. David's HealthCare
November 01, 2021

As the final steps are being taken by those working on the Phoenix study, the multi-center clinical trial studying the use of an exoskeleton for movement in spinal cord injury (SCI) patients has proved that there has been a significant change in walking performance among the diverse group of subjects. The Phoenix exoskeleton produced by SuitX has shown to be safe and feasible for SCI patients, as well as encouraging patients to achieve a certain level of independence as defined by the Functional Independence Measure. Seeking to present at the HKOA 38th Annual Congress on November 3-4 2018 at Hong Kong Convention and Exhibition Center.

tags: research